A desperately needed reset at the FDA

Marty Makary’s resignation as commissioner of the Food and Drug Administration creates a much-needed opportunity to reset the critical agency. It’s not an exaggeration to say that developing a more constructive relationship with medical innovators could benefit billions of people. What will happen...

Redirecting to full article...